Handelsbanken Fonder’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.5M | Buy |
50,502
+3,998
| +9% | +$2.1M | 0.09% | 202 |
|
2025
Q1 | $29.5M | Sell |
46,504
-1,650
| -3% | -$1.05M | 0.12% | 166 |
|
2024
Q4 | $34.3M | Sell |
48,154
-35,486
| -42% | -$25.3M | 0.13% | 152 |
|
2024
Q3 | $87.9M | Sell |
83,640
-3,461
| -4% | -$3.64M | 0.35% | 52 |
|
2024
Q2 | $91.5M | Sell |
87,101
-18,026
| -17% | -$18.9M | 0.4% | 43 |
|
2024
Q1 | $101M | Buy |
105,127
+10,087
| +11% | +$9.71M | 0.44% | 42 |
|
2023
Q4 | $83.5M | Sell |
95,040
-33,986
| -26% | -$29.8M | 0.41% | 46 |
|
2023
Q3 | $106M | Sell |
129,026
-4,532
| -3% | -$3.73M | 0.59% | 29 |
|
2023
Q2 | $96M | Sell |
133,558
-18,731
| -12% | -$13.5M | 0.51% | 36 |
|
2023
Q1 | $125M | Sell |
152,289
-28,290
| -16% | -$23.2M | 0.72% | 20 |
|
2022
Q4 | $130M | Sell |
180,579
-26,041
| -13% | -$18.8M | 0.82% | 18 |
|
2022
Q3 | $142M | Buy |
206,620
+12,300
| +6% | +$8.47M | 0.95% | 16 |
|
2022
Q2 | $115M | Sell |
194,320
-3,420
| -2% | -$2.02M | 0.75% | 21 |
|
2022
Q1 | $138M | Buy |
197,740
+14,000
| +8% | +$9.78M | 0.77% | 21 |
|
2021
Q4 | $116M | Buy |
183,740
+29,317
| +19% | +$18.5M | 0.57% | 29 |
|
2021
Q3 | $93.5M | Buy |
154,423
+134,000
| +656% | +$81.1M | 0.49% | 39 |
|
2021
Q2 | $11.4M | Sell |
20,423
-4,934
| -19% | -$2.76M | 0.06% | 304 |
|
2021
Q1 | $12M | Buy |
25,357
+637
| +3% | +$301K | 0.07% | 263 |
|
2020
Q4 | $11.9M | Sell |
24,720
-7,288
| -23% | -$3.52M | 0.07% | 252 |
|
2020
Q3 | $17.9M | Sell |
32,008
-13,335
| -29% | -$7.46M | 0.13% | 163 |
|
2020
Q2 | $28.3M | Buy |
45,343
+35,343
| +353% | +$22M | 0.24% | 93 |
|
2020
Q1 | $4.88M | Buy |
+10,000
| New | +$4.88M | 0.11% | 146 |
|
2017
Q1 | – | Sell |
-2,000
| Closed | -$734K | – | 175 |
|
2016
Q4 | $734K | Buy |
+2,000
| New | +$734K | 0.02% | 152 |
|
2016
Q1 | – | Sell |
-9,223
| Closed | -$5.01M | – | 507 |
|
2015
Q4 | $5.01M | Buy |
+9,223
| New | +$5.01M | 0.1% | 188 |
|